sq 20006 has been researched along with my 5445 in 1 studies
*MY 5445: potential platelet aggregation inhibitor [MeSH]
*MY 5445: potential platelet aggregation inhibitor [MeSH]
| Studies (sq 20006) | Trials (sq 20006) | Recent Studies (post-2010) (sq 20006) | Studies (my 5445) | Trials (my 5445) | Recent Studies (post-2010) (my 5445) |
|---|---|---|---|---|---|
| 8 | 0 | 0 | 25 | 0 | 6 |
| Protein | Taxonomy | sq 20006 (IC50) | my 5445 (IC50) |
|---|---|---|---|
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 1.975 | |
| cGMP-specific 3',5'-cyclic phosphodiesterase | Bos taurus (cattle) | 6.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballou, LM; Edelmann, HM; Petritsch, C; Woscholski, R | 1 |
1 other study(ies) available for sq 20006 and my 5445
| Article | Year |
|---|---|
Activation of p70 S6 kinase and erk-encoded mitogen-activated protein kinases is resistant to high cyclic nucleotide levels in Swiss 3T3 fibroblasts.
Topics: 3T3 Cells; 8-Bromo Cyclic Adenosine Monophosphate; Alprostadil; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Activation; Epidermal Growth Factor; Kinetics; Mice; Mitogen-Activated Protein Kinases; Nerve Tissue Proteins; Nicotinic Acids; Phosphatidylinositol 3-Kinases; Phosphodiesterase Inhibitors; Phosphotransferases (Alcohol Group Acceptor); Phthalazines; Protein Serine-Threonine Kinases; Ribosomal Protein S6 Kinases; Signal Transduction; Theophylline | 1995 |